All In MedTech

FDA Clearance Tracker · K230474

EVA5 Insufflator

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 19, 2026Latest source record: Mar 24, 2023 (this decision)Source: openFDAMethods & limitations

510(k)

Decided

Mar 24, 2023

Substantially Equivalent

Time to decision

30 days

Received Feb 22, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Special

Device class

Class II

The decision

FDA number
K230474
Device name
EVA5 Insufflator
Applicant location
Galway, IE
Received
Feb 22, 2023
Decided
Mar 24, 2023
Decision
Substantially Equivalent
Submission type
Special

Device type

Device class
Class II
Regulation
21 CFR 876.1500

Every decision under product code FCX

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code FCX. The earliest in FDA's data is K844689, decided Jan 2, 1985.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Palliare , Ltd.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.